Table 3 Adverse events [n (%)] occurring in ≥ 10% of subjects in any treatment group
Event | Treatment Regimen A (fasting; n= 28) | Treatment Regimen B (fed; n= 29) | Treatment Regimen C (fasting with naltrexone block; n= 27) |
|---|---|---|---|
Nausea | 6 (21.4) | 9 (31.0) | 7 (25.9) |
Asthenia | 6 (21.4) | 8 (27.6) | 7 (25.9) |
Dizziness | 8 (28.6) | 5 (17.2) | 3 (11.1) |
Pruritus | 2 (7.1) | 4 (13.8) | 9 (33.3) |
Headache | 6 (21.4) | 3 (10.3) | 4 (14.8) |
Vomiting | 2 (7.1) | 3 (10.3) | 5 (18.5) |